| Perioperative myeloid cell remodeling shapes CAR-T cell efficacy in glioblastoma | Nature communications |  | | 2026 | 1 | 1 |
|
| Preclinical efficacy of multi-targeting mRNA-based CAR T cell therapy in resection models of glioblastoma | Molecular therapy. Nucleic acids | | | 2025 | 1 | 0 |
|
| Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma | Journal for immunotherapy of cancer | | | 2025 | 1 | 1 |
|
| Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence | Nature biomedical engineering | | | 2025 | 31 | 17 |
|
